論文一覧
横スクロールして、ご覧ください。
| Title | Authors | Journal | Year | Vol | Pages |
|---|---|---|---|---|---|
| Two new adenopeptins B and C inhibit sphere formation of pancreatic cancer cells. | D. Tatsuda, M. Amemiya, C. Nosaka, R. Sawa, H. Muramatsu, M. Igarashi, J. Yoshida, T. Ohishi, and M. Kawada | J. Antibiot. | 2023 | https://doi.org/10.1038/s41429-023-00679-y | |
| Antiplasmodial activity evaluation of a bestatin-related aminopeptidase inhibitor, phebestin. | N. R. Ariefta, B. Pagmadulam, M. Hatano, N. Ikeda, K. Isshiki, K. Matoba, M. Igarashi, C. Nihei, and Y. Nishikawa | Antimicrob Agents Chemother. | 2023 | 67 | e0160622. doi: 10.1128/aac.01606-22 |
| Cycloimidamicins, Novel natural lead compounds for translation inhibition in Pseudomonas aeruginosa. | Y. Ishizaki, M. Umekita, R. Arisaka, M. Hatano, T. Kimura, Y. Kubota, Y. Shibuya, C. Hayashi, R. Sawa, and M. Igarashi | J. Antibiot. | 2023 | 76 | 691-698, https://doi.org/10.1038/s41429-023-00656-5 |
| Catalytic asymmetric vinylogous conjugate addition of butenolide to 2‑ester-substituted chromones: access to chiral chromanone lactones via trapping of a copper(I) enolate by trimethyl borate. | J. Cui, R. Oriez, S. Samanta, H. Noda, T. Watanabe, and M. Shibasaki | Organic Letters | 2023 | https://doi.org/10.1021/acs.orglett.3c03503 | |
| Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H2Mab-77-mG2a-f. | T. Tanaka, H. Suzuki, T. Ohishi, M. K. Kaneko, and Y. Kato | Cancer Science | 2023 | 00:1-12. DOI: 10.1111/cas.16008 | |
| anti-selective synthesis of substituted β-homoprolines by rhodium alkyl nitrene C–H insertion. | X. Tang, H. Noda, and M. Shibasaki | Synlett | 2023 | DOI: 10.1055/a-2201-7267 | |
| Examining the effects of additives and precursors on the reactivity of rhodium alkyl nitrenes generated from substituted hydroxylamines. | H. Noda, Y. Asada, and M. Shibasaki | Front. Chem. | 2023 | 11 | 1271896. (DOI: 10.3389/fchem.2023.1271896) |
| Comprehensive in virio structure probing analysis of the influenza A virus identifies functional RNA structures involved in viral genome replication. |
N. Takizawa, and R.K. Kawaguchi | Computational and Structural Biotechnology Journal | 2023 | 21 | 5259-5272. https://doi.org/10.1016/j.csbj.2023.10.036 |
| A humanized and defucosylated antibody against podoplanin (humLpMab-23-f) exerts antitumor activities in human lung cancer and glioblastoma xenograft models. | H. Suzuki, T. Ohishi, M. K. Kaneko, and Y. Kato | Cancers | 2023 | 15 | 5080. https://doi.org/10.3390/cancers15205080 |
| Protocol for real-time imaging of membrane fission by mitofissin. |
T. Maruyama, and N. N. Noda | STAR Protocols | 2023 | 4 | 102590, https://doi.org/10.1016/j.xpro.2023.102590 |
| Deoxynortryptoquivaline: A unique antiprostate cancer agent. | Y. Yamazaki, M. Kawada, and I. Momose | Oncology Research | 2023 | 31 | 845-853, Doi: 10.32604/or.2023.030266 |
| Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling. | M. Kawatani, H. Aono, S. Hiranuma, T. Shimizu, M. Muroi, T. Nogawa, T. Ohishi, S. Ohba, M. Kawada, K. Yamazaki, S. Dan, N. Dohmae, and H. Osada | Oncology Research | 2023 | 31 | 833-844, Doi: 10.32604/or.2023.030241 |
| Locking the conformation of a paddlewheel rhodium complex: design, synthesis, and applications in catalytic nitrene transfers. | X.Tang, H. Noda, and M. Shibasaki | Angewandte Chemie International Edition | 2023 | e202311027, https://doi.org/10.1002/anie.202311027 | |
| Defucosylated monoclonal antibody (H2Mab-139-mG2a-f) exerted antitumor activities in mouse xenograft models of breast cancers against human epidermal growth factor receptor 2. | H. Suzuki, T. Ohishi, R. Nanamiya, M. Kawada, M. K. Kaneko, and Y. Kato | Curr. Issues Mol. Biol. | 2023 | 45 | 7734-7748. htps://doi.org/10.3390/cimb45100488 |
| Pseudomonas aeruginosa theft biofilm require host lipids of cutaneous wound. | M. Sinha, N. Ghosh, D. S. Wijesinghe, S. S. M-Steiner, A. Das, K. Singh, M. El Masry, S. Khanna, H. Inoue, K. Yamazaki, M. Kawada, G. M. Gordillo, S. Roy, and C. K. Sen | Annals of Surgery | 2023 | 277 | e634-e647 |
| Therapeutic target of leukotriene B4 receptors, BLT1 and BLT2: insights from basic research. | M. Nakamaura, and T. Shimizu | Biochimie | 2023 | 214 | https://doi.org/10.1080/15548627.2023.2237343 |
| Lysophosphatidic acid, a simple phospholipid with myriad functions. | K. Yanagida, and T. Shimizu | Pharmacology & Therapeutics. | 2023 | 246 | 108421. https://doi.org/10.1016/j.pharmthera.2023.108421 |
| The leukotriene B4 receptors BLT1 and BLT2 as potential therapeutic targets. | T. Yokomizo, and T. Shimizu | Immunol. Rev. | 2023 | https://doi.org/10.1111/imr.13196 | |
| Inverse agonism of lysophospholipids with cationic head groups at Gi-coupled receptor GPR82. | D. Yasuda, F. Hamano, K. Masuda, M. Dahlstrom, D. Kobayashi, N. Sato, T. Hamakubo, T, Shimizu, and S. Ishii | Eur. J. Pharmacol. | 2023 | 954 | 175893. doi: 10.1016/j.ejphar.2023.175893. |
| LPGAT1/LPLAT7 regulates acyl chain profiles at the sn-1 position of phospholipids in murine skeletal muscles. | T. Sato, S. Umebayashi, N. Senoo, T. Akahori,H. Ichida, N. Miyoshi,T. Yoshida,Y. Sugiura, N. Goto-Inoue, H. Kawana, H. Shindou,T. Baba, Y. Maemoto, Y. Kamei, T. Shimizu, J. Aoki, and S. Miura | J. Biol. Chem. | 2023 | 299 | 104848. https://doi.org/10.1016/j.jbc.2023.104848 |
| Dietary omega-3 fatty acid does not improve male infertility caused by lysophospholipid acyltransferase 3 (LPLAT3/AGPAT3) deficiency. | K. Nagata, Y. Kakizaki, K. Yanagida, T. Arai, K. Nakano, F. Hamano, M. Goto, T. Okamura, T. Shimizu, and H. Shindou | Biochem. Biophys. Res. Commun. | 2023 | 663 | 179-185. doi: https://doi.org/10.1016/j.bbrc.2023.04.043 |
| Constitutively active GPR43 is crucial for proper leukocyte differentiation. | S. Miyasato, K. Iwata, R. Mura, S. Nakamura., K. Yanagida, H. Shindou, Y. Nagata, M. Kawahara, S. Yamaguchi, J. Aoki, A. Inoue, T. Nagamune, T. Shimizu, and M. Nakamura | FASEB J. | 2023 | e22676. doi: 10.1096/fj.202201591R. | |
| Mitofissin: a novel mitochondrial fission protein that facilitates mitophagy | T. Fukuda, K. Furukawa, T. Maruyama, N. N. Noda, and T. Kanki | Autophagy | 2023 | https://doi.org/10.1080/15548627.2023.2237343 | |
| The mitochondrial intermembrane space protein mitofissin drives mitochondrial fission required for mitophagy. | T. Fukuda, K. Furukawa, T. Maruyama, S. Yamashita, D. Noshiro, C. Song, Y. Ogasawara, K. Okuyama, J. Md. Alam, M. Hayatsu, T. Saigusa, K. Inoue, K. Ikeda, A. Takai, L. Chen, V. Lahiri, Y. Okada, S. Shibata, K. Murata, D. J. Klionsky, N. N. Noda, and T. Kanki | Molecular Cell | 2023 | 83 | 2045-2058. https://doi.org/10.1016/j.molcel.2023.04.022 |
| Coevolution of the ileum with Brk/Ptk6 family kinases confers robustness to ileal homeostasis. | I. Kikuchi, Y. Iwashita, A. Takahashi-Kanemitsu, M. Koebis, A. Aiba, and M. Hatakeyama | Biochem. Biophys. Res. Commun. | 2023 | 676 | 190-197. https://doi.org/10.1016/j.bbrc.2023.07.051 |
| The Helicobacter pyroli CagA oncoprotein disrupts Wnt/PCP signaling and promotes hyperproliferation of pyroli gland base cells. | A. Takahashi-Kanemitsu, M. Lu, C. T. Knight, T. Yamamoto, T. Hayashi, Y. Mii, T. Ooki, I. Kikuchi, A. Kikuchi, N. Barker, E. A. Susaki, M. Taira, and M. Hatakeyama | Sci. Signal | 2023 | 16 | https://doi.org/10.1126/scisignal.abp9020 |
| Exploring Allosteric inhibitors of protein tyrosine phosphatases through high-throughtput screening. | T. Hayashi and M. Hatakeyama | Methods Mol. Biol. | 2023 | 2691 | 235-245. doi: 10.1007/978-1-0716-3331-1_18. |
| Anti-inflammatory effects of dietary polyphenols through Inhibitory activity against metalloproteinases. | T. Suzuki, T. Ohishi, H. Tanabe, N. Miyoshi, and Y. Nakamura | Molecules | 2023 | 28 | 5426. https://doi.org/10.3390/molecules28145426 |
| Synthesis of novobiocin derivatives and evaluation of their antigonococcal activity and pharmacokinetics. | K. Sasaki, H. Takada, C. Hayashi, K. Ohya, Y. Yamaguchi, Y. Takahashi, M. Igarashi, and M. Shibasaki | Bioorg. Med. Chem. | 2023 | https://doi.org/10.1016/j.bmc.2023.117381 | |
| Non-Helicobacter pylori gastric microbiome modulates prooncogenic responses and is associated with gastric cancer risk. | R. Niikura, Y. Hayakawa, N. Nagata, T. Miyoshi-Akiayama, K. Miyabayashi, M. Tsuboi, N. Suzuki, M. Hata, J. Arai, K. Kurokawa, S. Abe, C. Uekura, K. Miyoshi, S. Ihara, Y. Hirata, A. Yamada, H. Fujiwara, T. Ushiku, S. L. Woods, D. L. Worthley, M. Hatakeyama, Y. W. Han, T. C. Wang, T. Kawai, and M. Fujishiro | Gastro Hep Advaces | 2023 | 2 | 684-700. https://www.ghadvances.org/article/S2772-5723(23)00045- |
| Pancreatic stromal cell-derived oncostatin M confers drug resistance to a multi-tyrosine kinase inhibitor in pancreatic cancer cells. | D. Tatsuda, J. Yoshida, T. Ohishi, and M. Kawada | Anticancer Res. | 2023 | 43 | 2477-2489. doi:10.21873/anticanres.16415 |
| Diet-mediated constitutive induction of novel IL-4+ ILC2 cells maintains intestinal homeostasis in mice. | W. Cui, Y. Nagano, S. Morita, T. Tanoue, H. Yamane, K. Ishikawa, T. Sato, M. Kubo, S. Hori, T. Taniguchi, M. Hatakeyama, K. Atarashi, and K. Honda | J. Exp. Med. | 2023 | 220 | https://doi.org/10.1084/jem.20221773 |
| Brønsted base-catalyzed direct 1,6-conjugate addition of butenolide to p-quinone methides. | J. Cui, S. Samanta, T. Watanabe, and M. Shibasaki | Asian Journal of Organic Chemistry | 2023 | https://doi.org/10.1002/ajoc.202300176 | |
| Azo-tagged C4N4 fluorophores: unusual overcrowded structures and their application to fluorescent imaging. | M. Kohei, N. Takizawa, R. Tsutsumi, W. Xu, and N. Kumagai | Org. Biomol. Chem. | 2023 | 21 | 2889-2893 |
| RNA structure determination by high-throughput structural analysis. | N. Takizawa | Methods Mol. Biol. | 2023 | 2586 | 217-231 |
| Aprosamine derivatives active against multidrug-resistant gram-negative bacteria. | Y. Otsuka, E. Umemura, Y. Takamiya, T. Ishibashi, C. Hayashi, K. Yamada, M. Igarashi, M. Shibasaki, and Y. Takahashi | ACS Infectious Diseases | 2023 | 9 | 886-898 |
| Helicobacter pylori, homologus-recombination genes, and gastric cancer. | Y. Usui, Y. Taniyama, M. Endo, Y.N. Koyanagi, Y. Kasugai, I. Oze, H. Ito, I. Imoto, T. Tanaka, M. Tajika, Y. Niwa, Y. Iwasaki, T. Aoi, N. Hakozaki, S. Takata, K. Suzuki, C. Terao, M. Hatakeyama, M. Hirata, K. Sugano, T. Yoshida, Y. Kamatani, H. Nakagawa, K. Matsuda, Y. Murakami, A.B. Spurdle, K. Matsuo, and Y. Momozawa | New Eng. J. Med. | 2023 | 388 | 1181-1190. doi: 10.1056/NEJMoa2211807 |
| がんエネルギー代謝を標的とした創薬 | 吉田潤次郎、大石智一、川田学 | 腫瘍内科 | 2023 | 31 | 102-108 |
| Less is more: N(BOH)2 configuration exhibits higher reactivity than the B3NO2 heterocycle in catalytic dehydrative amide formation. | C. R. Opie, H. Noda, M. Shibasaki, and N. Kumagai | Org. Lett. | 2023 | 25 | 694-697, https://pubs.acs.org/doi/10.1021/acs.orglett.2c04382 |
| Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models. | G. Li, H. Suzuki, T. Ohishi, T. Asano, T. Tanaka, M. Yanaka, T. Nakamura, T. Yoshikawa, M. Kawada, M. K. Kaneko, and Y. Kato | International Journal of Molecular Medicine | 2023 | 51 | 18. https://doi.org/10.3892/ijmm.2023.5221 |
| Current targeted therapy for metastatic colorectal cancer. | T. Ohishi, M. K. Kaneko, Y. Yoshida, A. Takashima, Y. Kato, and M. Kawada | Int. J. Mol. Sci. | 2023 | 24 | 1702. https://doi.org/10.3390/ijms24021702 |
| A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression. | S. Takase, T. Hiroyama, F. Shirai, Y. Maemoto, A. Nakata, M. Arata, S. Matsuoka, T. Sonoda, H. Niwa, S. Sato, T. Umehara, M. Shirouzu, Y. Nishigaya, T. Sumiya, N. Hashimoto, R. Namie, M. Usui, T. Ohishi, S. Ohba, M. Kawada, Y. Hayashi, H. Harada, T. Yamaguchi, Y. Shinkai, Y. Nakamura, M. Yoshida, and A. Ito |
Nature Communications | 2023 | 14 | 23. https://doi.org/10.1038/s41467-022-35404-0 |
| Asymmetric syn-selective vinylogous addition of butenolides to chromones via Al-Li-BINOL catalysis. | S. Samanta, J. Cui, H. Noda, T. Watanabe, and M. Shibasaki | J. Org. Chem. | 2023 | 88 | 1177-1184. https://doi.org/10.1021/acs.joc.2c02731 |
| Effects of epigallocatechin-3-gallate on matrix metalloproteinases in terms of its anticancer activity. |
H. Tanabe, T. Suzuki, T. Ohishi, M. Isemura, Y. Nakamura, and K. Unno | Molecules | 2023 | 28 | 525. https://doi.org/10.3390/molecules28020525 |